Pharma companies hit by employee misunderstanding; millions of dollars lost

20 July 2008

UK and US employees are costing businesses $37.0 billion every year because they do not fully understand their jobs, according to a new IDC white paper commissioned by Cognisco, a leading intelligent employee assessment specialist. $37 billion: Counting the Cost of Employee Misunderstanding reveals for the first time the scale and impact on businesses of employee misunderstanding, specifically among the banking, petrochemical, pharmaceuticals and transportation sectors.

Employee misunderstanding is defined as actions taken by employees who have misunderstood ormisinterpreted (or were misinformed about or lack confidence in their understanding) of company policies, business processes, job function or a combination of the three. The white paper revealed that the pharmaceutical industry had one of the highest potential costs of employee misunderstanding. When this was extrapolated to the whole sector, it found that UK pharmaceutical companies could lose $46.8 million each year.

Unplanned downtime reported by 37%

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight